197 related articles for article (PubMed ID: 9112058)
1. Actual use of inhaled corticosteroids and risk of hospitalisation: a case-control study.
van Ganse E; Hubloue I; Vincken W; Leufkens HG; Gregoire J; Ernst P
Eur J Clin Pharmacol; 1997; 51(6):449-54. PubMed ID: 9112058
[TBL] [Abstract][Full Text] [Related]
2. Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications.
Herborg H; Soendergaard B; Jorgensen T; Fonnesbaek L; Hepler CD; Holst H; Froekjaer B
J Am Pharm Assoc (Wash); 2001; 41(4):551-9. PubMed ID: 11486981
[TBL] [Abstract][Full Text] [Related]
3. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
4. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
5. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM
Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.
Salpeter SR; Wall AJ; Buckley NS
Am J Med; 2010 Apr; 123(4):322-8.e2. PubMed ID: 20176343
[TBL] [Abstract][Full Text] [Related]
7. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
8. Noncompliance and treatment failure in children with asthma.
Milgrom H; Bender B; Ackerson L; Bowry P; Smith B; Rand C
J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1051-7. PubMed ID: 8977504
[TBL] [Abstract][Full Text] [Related]
9. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
10. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
11. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ; Jaeschke R
Cochrane Database Syst Rev; 2009 Apr; (2):CD006924. PubMed ID: 19370661
[TBL] [Abstract][Full Text] [Related]
12. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
[TBL] [Abstract][Full Text] [Related]
13. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ; Jaeschke R
Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events.
Bateman E; Nelson H; Bousquet J; Kral K; Sutton L; Ortega H; Yancey S
Ann Intern Med; 2008 Jul; 149(1):33-42. PubMed ID: 18523132
[TBL] [Abstract][Full Text] [Related]
15. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
Hancox RJ; Taylor DR
BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672
[TBL] [Abstract][Full Text] [Related]
16. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
Virchow JC; Prasse A; Naya I; Summerton L; Harris A
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
[TBL] [Abstract][Full Text] [Related]
17. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.
Fahy JV; Boushey HA
Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.
Ernst P; McIvor A; Ducharme FM; Boulet LP; FitzGerald M; Chapman KR; Bai T;
Ann Intern Med; 2006 Nov; 145(9):692-4. PubMed ID: 17088583
[TBL] [Abstract][Full Text] [Related]
19. Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma.
Wang MT; Skrepnek GH; Armstrong E; Sherrill DL; Harris RB; Tsai CL; Malone DC
Curr Med Res Opin; 2008 Mar; 24(3):859-67. PubMed ID: 18267052
[TBL] [Abstract][Full Text] [Related]
20. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
